MedPath

ZTE MRI Pulse Sequence Use for Visualization of Bone Cement, Breast Biopsy Markers

Recruiting
Conditions
Breast Carcinoma
Registration Number
NCT06873802
Lead Sponsor
Mayo Clinic
Brief Summary

This study is being done to determine if a clinically available MRI sequence called ZTE imaging better visualizes breast biopsy markers made of bone cement compared to the currently used breast biopsy markers made of metal.

Detailed Description

PRIMARY OBJECTIVE:

I. To demonstrate that clinically available ZTE imaging allows for better visualization of bone cement breast biopsy markers when compared to conventional breast biopsy markers and pulse sequences.

OUTLINE: This is an observational study.

Participants undergo standard of care MRI breast imaging with conventional or bone cement breast biopsy markers and complete a questionnaire on study.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Age of 18 or older
Exclusion Criteria
  • Cardiac pacemaker

  • Implanted cardiac defibrillator

  • Internal pacing wires

  • Cerebral, carotid, or aortic aneurysmal clips

  • Cochlear implants

  • Implanted tissue expanders

  • Claustrophobia

  • Cannot lay prone

    • Pregnant

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bone cement marker (BCM) images compared to conventional imagesBaseline

Will be assessed using zero echo-time (ZTE) and standard breast biopsy pulse sequences. Two radiologists will interpret images, evaluating the pulse sequences and ZTE images for marker conspicuity. Each sequence will receive a score for conspicuity ranging from 0 to 2. A score of 0 indicates 'not seen, 1 'maybe seen,' and 2 'well seen.'

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mayo Clinic in Rochester

🇺🇸

Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath